Class of 2024
For revolutionizing the understanding of how genomic rearrangements occur, elucidating their role in cancer development and progression, and for discovering dihydrofolate reductase gene amplification in methotrexate-resistant cancer cells and MYCN amplification in neuroblastoma, as well as discovering the mechanisms regulating V(D)J recombination to form exons that encode antibody variable regions.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]